Fosamax, a bisphosphonate medication
used to treat osteoporosis, is currently under investigation by the FDA after
receiving reports of a few unusual types of leg fractures. Many
postmenopausal women take this medication, or a similar medication, for bone
protection. This has caused concern with some of my patients who saw the
original news report.
What you need to know. So far, FDA has found no clear connection between bisphosphonates and the risk of atypical femur fractures. The number of women who experienced an atypical fracture is very low. In comparison, 50% of women will experience an osteoporosis related fracture.
Until more is known, the National Osteoporosis Foundation recommends: